A study to test the efficacy of a unique cannabis terpene formulation for the treatment of viral infections, including COVID-19, has shown early promising results.
An allergy doctor says vaccine reaction risk is extremely low and the chances are greater that someone would have a bad outcome from COVID-19. (Dec. 17)
AP Domestic
Kinshasa, Democratic Republic of the Congo — Showing early symptoms of hemorrhagic fever, the patient sits quietly on her bed, wrangling two toddlers desperate to flee the cell-like hospital room in Ingende, a remote town in the Democratic Republic of the Congo (DRC).
